頁籤選單縮合
題名 | 臺灣地區代謝症候群相關疾病改善之經濟效益=Evaluating the Benefits of Ameliorating Metabolic-Syndrome-Related Diseases in Taiwan |
---|---|
作者姓名(中文) | 盧介祥; 李杰憲; 盧永祥; 鍾憲瑞; 莊向薰; | 書刊名 | 臺灣經濟預測與政策 |
卷期 | 45:1 2014.10[民103.10] |
頁次 | 頁77-111 |
專輯 | 「社會成本效益分析」特刊 |
分類號 | 415.593 |
關鍵詞 | 代謝症候群相關疾病; 旅行成本法; 消費者剩餘; 經濟效益; Metabolic-syndrome-related diseases; Travel cost method; Consumer surplus; Economic benefits; |
語文 | 中文(Chinese) |
中文摘要 | 本文應用旅行成本法的概念及迴歸模型估計臺閩地區代謝症候群相關疾病罹病者的醫療照護需求函數,並藉由觀察罹病者醫療照護需求及消費者剩餘的變化,探討改善罹病者的健康指標時所能產生的經濟效益。實證結果顯示,若能分別改善臺閩地區代謝症候群相關疾病罹病者的血壓值、膽固醇值及身體質量指數狀況至臨界值的水準,亦即消除高血壓、高膽固醇及過重之風險因子,則可減少個人醫療成本約為11.34億元、2.69億元及4.97億元;可減少總醫療成本約為33.41億元、7.94億元及14.64億元;亦可獲得健康指標改善之經濟效益約為124.54億元、29.83億元及54.89億元。 |
英文摘要 | This paper uses the travel cost method and regression model to evaluate the benefits of ameliorating metabolic-syndrome-related diseases in Taiwan. Data from the "Ditmanson Medical Foundation Cha-Yi Christian Hospital" and National Health Insurance (NHI) are used for the empirical analysis. The results show that if we can ameliorate risk factors such as hypertension, cholesterol and overweight among metabolic-syndrome-related diseases sufferers so that the risk levels are no higher than level found in the general population, the benefits of ameliorating disease are that the cost of medical service can be reduced NT$ 3.341,$0.794 and $1.464 billion, then add economic benefits NT$12.454, $2.983 and $5.489 billion respectively in Taiwan. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。